Connect with us

CBD News

New Frontier Data: Pharmaceutical Industry, aka Big Pharma, Could Lose Nearly $20 Million to Cannabis

Andie Francese

Published

on

New Frontier Data: Pharmaceutical Industry, aka Big Pharma, Could Lose Nearly $20 Million to Cannabis
- Ad -

New Frontier Data, an investigation firm, released a new report concerning the impact of introducing cannabis to the pharmaceutical industry. Giadha Aguirre De Carcer, the firm’s CEO, commented on the issue in an article by Civiled, stating

“If cannabis somehow managed to be adopted nationally, we would start to see a pattern of patients turning to medicinal marijuana as a substitute or a sequel to pharmaceuticals”

The report addressed nine medical conditions that could be treated by cannabis effectively. These conditions include glaucoma, Tourette syndrome, epilepsy, nerve pain, anxiety, and post-traumatic stress disorder. Meaning, it may not always be effective to treat these conditions with pharmaceutical drugs.

The report also delved into a 2016 Health Affairs study, which found that states that had legalized marijuana had an 11 percent reduction in drug prescriptions. The report then addressed what it estimates the drop would be if marijuana were to be legalized nationwide. Ultimately, it estimated that cannabis and related products can replace $4.4 billion to $4.9 billion per year of the money spent on existing treatments. Aguirre de Carcer added,

“However, when you start to break down the numbers by specific sectors of the industry, like chronic pain or symptoms associated with chemotherapy, which are very lucrative markets for pharmaceutical companies, you will certainly see cannabis have a major impact.”

Andie Francese is a professional content consultant living in New York. In her copywriting career, as the leader of a group of award-winning journalists, Andrea was always gifted in organizing and optimizing teams of all sizes into creating and crafting valuable guides and insightful information into the topics presented to her acclaimed status. TOC is very excited to have her as part of our growing team.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com